| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 673,9 k € | +6.1% | 635,4 k € | -1.8% | 647,1 k € | +11.7% | 579,1 k € | +17.4% | 493,4 k € | +20.0% | 411,2 k € | -32.5% | 609,2 k € | +24.0% | 491,1 k € | -6.9% | 527,3 k € | +17.4% | 449,2 k € | -30.7% | 647,7 k € | +21.8% | 531,7 k € | -0.7% | 535,7 k € | -9.0% | 588,9 k € | -13.3% | 679,2 k € | +18.2% | 574,4 k € | -0.2% | 575,7 k € | +1.7% | 566,3 k € | +36.6% | 414,5 k € | |
| EBITDA | 595,8 k € | +8.9% | 547,1 k € | -3.4% | 566,6 k € | +12.9% | 501,9 k € | +17.9% | 425,6 k € | +33.8% | 318,0 k € | -38.2% | 514,5 k € | +29.8% | 396,3 k € | -11.1% | 445,8 k € | +19.7% | 372,4 k € | -35.7% | 579,0 k € | +18.1% | 490,4 k € | -1.8% | 499,3 k € | -10.3% | 556,6 k € | -14.2% | 649,0 k € | +17.9% | 550,6 k € | -3.6% | 571,4 k € | +1.4% | 563,2 k € | +36.6% | 412,2 k € | |
| Operating profit | 537,0 k € | +11.1% | 483,5 k € | -7.6% | 523,3 k € | +20.1% | 435,7 k € | +34.9% | 322,9 k € | +56.0% | 207,0 k € | -43.3% | 364,8 k € | +91.1% | 190,9 k € | -31.8% | 280,0 k € | +40.6% | 199,1 k € | -48.4% | 385,6 k € | +29.6% | 297,6 k € | -9.6% | 329,2 k € | -17.3% | 398,2 k € | -18.9% | 490,8 k € | +24.7% | 393,6 k € | -0.9% | 397,1 k € | +5.2% | 377,7 k € | +50.1% | 251,7 k € | |
| Profit/loss | 385,2 k € | +7.8% | 357,4 k € | -10.0% | 397,1 k € | +37.3% | 289,1 k € | +44.5% | 200,0 k € | +32.3% | 151,2 k € | -36.5% | 238,2 k € | +115.9% | 110,3 k € | -31.3% | 160,7 k € | +75.0% | 91,9 k € | -55.3% | 205,4 k € | +16.3% | 176,6 k € | -26.7% | 240,7 k € | +45.9% | 165,0 k € | -45.8% | 304,7 k € | +7.6% | 283,3 k € | +30.6% | 217,0 k € | -9.9% | 240,9 k € | +38.6% | 173,8 k € | |
| Equity | 2,0 M € | +12.6% | 1,8 M € | +16.5% | 1,5 M € | +24.2% | 1,2 M € | -5.8% | 1,3 M € | +18.4% | 1,1 M € | +16.1% | 938,7 k € | +34.0% | 700,5 k € | -9.0% | 770,1 k € | +26.4% | 609,4 k € | +17.7% | 517,6 k € | +65.8% | 312,1 k € | -34.4% | 475,6 k € | +102.5% | 234,8 k € | +236.5% | 69,8 k € | -92.6% | 941,6 k € | +43.0% | 658,2 k € | -50.4% | 1,3 M € | +22.2% | 1,1 M € | |
| Total assets | 2,1 M € | +12.0% | 1,9 M € | +14.1% | 1,7 M € | +24.5% | 1,3 M € | -31.7% | 2,0 M € | +6.2% | 1,9 M € | -31.5% | 2,7 M € | +3.4% | 2,6 M € | +2.6% | 2,6 M € | +5.2% | 2,4 M € | +1.0% | 2,4 M € | +3.7% | 2,3 M € | -1.7% | 2,4 M € | +4.9% | 2,2 M € | +33.8% | 1,7 M € | +2.2% | 1,6 M € | -9.4% | 1,8 M € | +7.2% | 1,7 M € | +8.0% | 1,6 M € | |
| Cash | 306,6 k € | -70.1% | 1,0 M € | -6.5% | 1,1 M € | +10.8% | 989,4 k € | -39.3% | 1,6 M € | +11.2% | 1,5 M € | +15.4% | 1,3 M € | +18.1% | 1,1 M € | +11.0% | 969,1 k € | +36.3% | 711,0 k € | +29.6% | 548,5 k € | +69.2% | 324,1 k € | +4.6% | 310,0 k € | -34.5% | 473,0 k € | -18.2% | 578,0 k € | +14.0% | 507,0 k € | -24.8% | 674,0 k € | +232.2% | 202,9 k € | -6.7% | 217,4 k € | |
| Debts | 161,7 k € | +5.2% | 153,7 k € | -7.8% | 166,7 k € | +38.8% | 120,2 k € | -81.8% | 660,6 k € | -11.5% | 746,4 k € | -57.3% | 1,7 M € | -7.9% | 1,9 M € | +7.8% | 1,8 M € | -1.9% | 1,8 M € | -4.1% | 1,9 M € | -5.6% | 2,0 M € | +6.2% | 1,9 M € | -6.9% | 2,0 M € | +24.9% | 1,6 M € | +129.7% | 700,2 k € | -39.2% | 1,2 M € | +220.7% | 359,3 k € | -23.6% | 470,1 k € | |
| Staff | 1,5 | 2 | 2 | 2 | 2 | 2,5 | 2,7 | 2,6 | 2,4 | 2,5 | 2,2 | 1,7 | 1,3 | 1,3 | 1,2 | 0,8 | 0,1 | — | — | |||||||||||||||||||
Private limited company · Watermael-Boitsfort · incorporated on 16/04/1999 · 1,5 ETP
Private limited company profitable and well capitalised. Cash position declining (-70.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
B.G. OPHTALMO is a Private limited company incorporated in 1999. Its main activity is: Specialist medical practice activities. Its registered office is in Watermael-Boitsfort. It employs on average 1,5 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette